Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Stemcell United Ltd. ( (AU:BP8) ) has shared an announcement.
BPH Global Ltd has launched a low-risk research and development program to evaluate the use of non-export grade Eucheuma cottonii seaweed in animal feed and feed supplement applications, aiming to utilise biologically active material that falls outside export specifications. The initiative, which leverages existing Indonesian sourcing and operational infrastructure, will examine nutritional value, functional bioactive properties, potential methane-reduction effects, and processing methods, with the goal of improving raw material utilisation, reducing waste, enhancing margin resilience and supporting ESG objectives, without altering the company’s core seaweed trading and export business at this stage.
The most recent analyst rating on (AU:BP8) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Stemcell United Ltd. stock, see the AU:BP8 Stock Forecast page.
More about Stemcell United Ltd.
BPH Global Ltd is an ASX-listed company operating a seaweed trading and export business in Indonesia, sourcing Eucheuma cottonii from established farming regions in Maluku and Luwuk. Its core operations focus on supplying high-quality seaweed that meets strict commercial specifications for carrageenan-related applications in export markets.
Current Market Cap: A$2.78M
For detailed information about BP8 stock, go to TipRanks’ Stock Analysis page.